10074-A4
CAS No. 312631-87-1
10074-A4( —— )
Catalog No. M28813 CAS No. 312631-87-1
10074-A4 is a c-Myc binding compound that associates with c-Myc370–409 and behaves like a “ligand cloud” around a “protein cloud”, with distinct features from that of a non-binding ligand.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 103 | In Stock |
|
| 2MG | 73 | In Stock |
|
| 5MG | 117 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 335 | In Stock |
|
| 50MG | 470 | In Stock |
|
| 100MG | 647 | In Stock |
|
| 200MG | 872 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name10074-A4
-
NoteResearch use only, not for human use.
-
Brief Description10074-A4 is a c-Myc binding compound that associates with c-Myc370–409 and behaves like a “ligand cloud” around a “protein cloud”, with distinct features from that of a non-binding ligand.
-
Description10074-A4 is a c-Myc binding compound that associates with c-Myc370–409 and behaves like a “ligand cloud” around a “protein cloud”, with distinct features from that of a non-binding ligand.(In Vitro):10074-A4 showed binding affinity with c-Myc370–409 with Kd of 36.3 ± 9.0 μM and EC50 of 15.1 ± 2.3 μM.10074-A4 arrests the cell cycle at the S-phase in a dose-dependent manner in HL-60 cells.
-
In Vitro10074-A4 shows inhibitory activity of HL-60 cells with an IC50 of 15.1?μM.10074-A4 (25-50 μM; 24 hours) arrests the cell cycle at the S-phase in a dose-dependent manner in HL-60 cells. 10074-A4 inhibits the mRNA level of the c-Myc target genes, CCND2 and CDK4.10074-A4 could bind to c-Myc370-409 at different sites along the peptide chain and its binding behavior could be described as a ‘ligand cloud’. Even in the bound state, the structure of the c-Myc370-409 peptide remained a dynamic ensemble. The 10074-A4 ligand bound at different sites throughout the c-Myc370-409 chain with different strength. Cell Viability Assay Cell Line:HL-60 cells Concentration:25 μM, 50 μM Incubation Time:24 hours Result:Arrested the cell cycle at the S-phase.
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
Targetc-Myc
-
RecptorFerroptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number312631-87-1
-
Formula Weight409.28
-
Molecular FormulaC18H14Cl2N2O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (305.41 mM)
-
SMILESOC(CN1C(=O)CSC1=O)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gaschler MM, et al. FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol. 2018 May;14(5):507-515.
molnova catalog
related products
-
IRES-J007
An improved IRES inhibitor that blocks IRES-hnRNP A1 binding.
-
MYCi975
MYCi975 is an orally active inhibitor of MYC.MYCi975 inhibits P493-6, MV411,SK-N-B2 cells viability in an MYC-dependent manner(IC50s of 3.7, 3.9, 6.4 μM, respectively).The initial lead, MYC inhibitor 361 (MYCi361), suppressed in vivo tumor growth in mice, increased tumor immune cell infiltration, upregulated PD-L1 on tumors, and sensitized tumors to anti-PD1 immunotherapy. However, 361 demonstrated a narrow therapeutic index.
-
BTYNB
BTYNB is a potent and selective inhibitor of IMP1 binding to c-Myc mRNA with IC50 of 5 uM.
Cart
sales@molnova.com